Researcher Profiles

Return to member profile

X. F. Steven Zheng, PhD

Publications since 2011

Che, M. Wang, R. Wang, H. Y. Zheng, X. F. Expanding roles of superoxide dismutases in cell regulation and cancer. Drug Discov Today, In process, . (PMID: 26475962)

Cha, Y. L. Li, P. D. Yuan, L. J. Zhang, M. Y. Zhang, Y. J. Rao, H. L. Zhang, H. Z. Zheng, X. F. Wang, H. Y. EIF4EBP1 Overexpression Is Associated with Poor Survival and Disease Progression in Patients with Hepatocellular Carcinoma. PLoS One, 10:e0117493, . (PMID: 25658620)

Thomas, J. D. Zhang, Y. J. Wei, Y. H. Cho, J. H. Morris, L. E. Wang, H. Y. Zheng, X. F. Rab1A Is an mTORC1 Activator and a Colorectal Oncogene. Cancer Cell, 26:754-769, . (PMID: 25446900)

Tsang, C. K. Liu, Y. Thomas, J. Zhang, Y. Zheng, X. F. Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance. Nat Commun, 5:3446, . (PMID: 24647101)

Peng, H. S. Liao, M. B. Zhang, M. Y. Xie, Y. Xu, L. Zhang, Y. J. Zheng, X. F. Wang, H. Y. Chen, Y. F. Synergistic inhibitory effect of hyperbaric oxygen combined with sorafenib on hepatoma cells. PLoS One, 9:e100814, . (PMID: 24956259, PMCID: PMC4067386)

Wei, R. Huang, G. L. Zhang, M. Y. Li, B. K. Zhang, H. Z. Shi, M. Chen, X. Q. Huang, L. Zhou, Q. M. Jia, W. H. Zheng, X. F. Yuan, Y. F. Wang, H. Y. Clinical Significance and Prognostic Value of microRNA Expression Signatures in Hepatocellular Carcinoma. Clin Cancer Res, 19:4780-4791, . (PMID: 23812667)

Don, A. S. Tsang, C. K. Kazdoba, T. M. D'Arcangelo, G. Young, W. Zheng, X. F. Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries. Drug Discov Today, 17:861-868, . (PMID: 22569182, PMCID: PMC3411916)

Zheng, X. F. Chemoprevention of age-related macular regeneration (AMD) with rapamycin. Aging (Albany NY), 4:375-376, . (PMID: 22796653, PMCID: PMC3409673)

Zhang, Y. Zheng, X. F. mTOR-independent 4E-BP1 phosphorylation is associated with cancer resistance to mTOR kinase inhibitors. Cell Cycle, 11:594-603, . (PMID: 22262166, PMCID: PMC3315097)

Zhang, Y. J. Duan, Y. Zheng, X. F. Targeting the mTOR kinase domain: the second generation of mTOR inhibitors. Drug Discov Today, 16:325-331, . (PMID: 21333749, PMCID: PMC3073023)

Arachchige Don, A. S. Zheng, X. F. Recent Clinical Trials of mTOR-Targeted Cancer Therapies. Rev Recent Clin Trials, 6:24-35, . (PMID: 20868343)

Wei, Y. Zheng, X. F. Nutritional control of cell growth via TOR signaling in budding yeast. Methods Mol Biol, 759:307-319, . (PMID: 21863495)